http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-112013005622-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-455
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4427
filingDate 2011-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c003d994ad83a762dbcd17ab87ccbd42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_903c59a9f5c756585394ecbba0db942a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c42bbd4a3d2642d5d5937b08fc8d482
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_898b65071f5348e0bc447069dfe2ebc7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_38d8a4f8bb4df3fef089004cfb9cc415
publicationDate 2016-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-112013005622-A2
titleOfInvention heteroaryl methyl amides
abstract heteroaryl methyl amides. The present invention relates to the compounds of formula I wherein a ^ 1 ^, a ^ 2 ^, a ^ 3 ^ and a ^ 1 ^ ar ^ 8 ^ are defined therein, their manufacture, pharmaceutical compositions containing them and their derivatives. uses as medicaments for the treatment and / or prophylaxis of diseases which may be treated with HDL cholesterol elevating agents, such as particularly dyslipidemia, atherosclerosis and cardiovascular disease.
priorityDate 2010-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5997
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507953

Total number of triples: 33.